Today’s Solutions: November 14, 2024

Though the venom of some scorpions can deliver pain, and occasionally death, to humans, scorpion venom is used in a number of medical fields, including cancer research. Recently, for instance, scientists have developed an imaging technique that uses a synthetic version of a compound found in scorpion venom to make brain tumors easier to see.

Treating gliomas, a lethal kind of brain tumor, can be incredibly difficult. These tumors don’t respond well to conventional chemo or radiotherapy, and they tend to spread across a wide spectrum of brain tissue, making it difficult for surgeons to easily detect and remove all of the cancerous tissue.

By administering the compound from the scorpion venom to patients with gliomas along with a fluorescent dye, surgeons are able to identify the tumor more clearly, and thus, remove it more easily.The novel imaging technique is currently undergoing broader clinical trialing, including a study involving pediatric brain cancer, ahead of a hopeful FDA approval in the near future.

Solutions News Source Print this article
More of Today's Solutions

Two Black women to serve together in the United States Senate in a historic f...

BY THE OPTIMIST DAILY EDITORIAL TEAM For the first time in American history, two Black women will serve together in the Senate. Angela Alsobrooks, ...

Read More

Resilient community-building: staying safe in times of uncertainty

BY THE OPTIMIST DAILY TEAM Recent global and domestic developments have left many feminists and allies feeling uneasy, uncertain about their place in society, ...

Read More

3 lifestyle hacks to help you become a little happier

There is no one path to finding happiness, but there are some lifestyle changes you can make to become more receptive to happiness. Without ...

Read More

For the first time ever, Greece meets energy demands with 100% renewables

The other week, Greece celebrated an exciting milestone! All of the country’s electricity needs were met by renewable energy for the first time, as ...

Read More